Hepatitis C - Pipeline Review, H1 2016
Hepatitis C - Pipeline Review, H1 2016
Summary
Global Markets Directs, Hepatitis C - Pipeline Review, H1 2016, provides an overview of the Hepatitis C pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Hepatitis C, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Hepatitis C and features dormant and discontinued projects.
Browse Market info, get a Sample PDF with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=719497
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Click to submit Query/ Enquiry: http://www.researchmoz.us/enquiry.php?type=E&repid=719497
Table of Contents
Table of Contents 2
Introduction 7
Hepatitis C Overview 8
Therapeutics Development 9
Hepatitis C Therapeutics under Development by Companies 11
Hepatitis C Therapeutics under Investigation by Universities/Institutes 19
Hepatitis C Pipeline Products Glance 21
Hepatitis C Products under Development by Companies 25
Hepatitis C Products under Investigation by Universities/Institutes 38
Hepatitis C Companies Involved in Therapeutics Development 40
Hepatitis C Therapeutics Assessment 124
Drug Profiles 144
Hepatitis C Recent Pipeline Updates 422
Hepatitis C - Dormant Projects 518
Hepatitis C Discontinued Products 543
Hepatitis C Product Development Milestones 551
Appendix 561
About ResearchMoz
ResearchMoz is the worlds fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMozs service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket
Albany NY - 12207
United States
Tel: +1-518-621-2074
Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Latest Press-Releases: http://www.researchmoz.us/pressrelease